Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

417 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk of major congenital malformations associated with first-trimester antihypertensives, including amlodipine and methyldopa: A large claims database study 2010-2019.
Ishikawa T, Nishigori H, Akazawa M, Miyakoda K, Noda A, Ishikuro M, Metoki H, Iwama N, Saito M, Sugawara J, Kawame H, Yaegashi N, Kuriyama S, Mano N, Obara T. Ishikawa T, et al. Among authors: mano n. Pregnancy Hypertens. 2023 Mar;31:73-83. doi: 10.1016/j.preghy.2023.01.001. Epub 2023 Jan 9. Pregnancy Hypertens. 2023. PMID: 36646019
Combination of taking neuropsychiatric medications and psychological distress in pregnant women, with behavioral problems in children at 2 years of age: The Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study.
Takahashi I, Obara T, Kikuchi S, Kobayashi N, Obara R, Noda A, Ohsawa M, Ishikawa T, Mano N, Nishigori H, Ueno F, Shinoda G, Murakami K, Orui M, Ishikuro M, Tomita H, Kuriyama S. Takahashi I, et al. Among authors: mano n. PCN Rep. 2024 Jul 25;3(3):e226. doi: 10.1002/pcn5.226. eCollection 2024 Sep. PCN Rep. 2024. PMID: 39071169 Free PMC article.
Decreased serum levels of IL-4 correlate with the efficacy of the PAI-1 inhibitor TM5614 in patients with malignant melanoma refractory to anti-PD-1 antibodies: post hoc study of TM5614-MM trial.
Yamazaki E, Fujimura T, Takahashi-Watanabe M, Tada S, Kitayama C, Amagai R, Kambayashi Y, Watanabe M, Maekawa M, Mano N, Asano Y. Yamazaki E, et al. Among authors: mano n. Br J Dermatol. 2024 Aug 31:ljae343. doi: 10.1093/bjd/ljae343. Online ahead of print. Br J Dermatol. 2024. PMID: 39215562 No abstract available.
417 results